Drug Pipeline

anti-CD19 CAR-T cells Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT06227026
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the…		 date change Primary completion pushed: 2026-05 -> 2026-07
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT04545762 Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory… Refractory Non-Hodgkin Lymphoma Recruiting
NCT06227026 Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the… Acute Lymphoblastic Leukemia Recruiting
NCT07544225 Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave… Rheumatoid Arthritis (RA) Not Yet Recruiting
Sponsors Running anti-CD19 CAR-T cells Trials
C. Babis Andreadis (1) University of Utah (1) Gustave Roussy, Cancer Campus, Grand Paris (1)
Disease Areas
Non-Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1) Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1) Rheumatoid Arthritis (1) Lupus (SLE) (1) Scleroderma (1)
Get alerts when anti-CD19 CAR-T cells trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free